Progenics Pharmaceuticals Announces Presentations at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2019 Annual Meeting

by NASDAQ Market News June 6, 2019

NASDAQ Market News
Click here to email author

Three-Year Clinical Trial Results Support ILUVIEN® Launch in Europe for the Prevention of Relapse in Recurrent Non-Infectious Uveitis Affecting the Posterior Segment

New Studies Highlight Potential for T2Bacteria and T2Candida Panels to Improve Outcomes and be Cost-Effective for Sepsis Patients in the Medical Intensive Care Unit and Emergency Department

Ads